[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:autism-related-irritability":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Autism-Related Irritability",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07424404","A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively",[11],"Phase 3","RECRUITING","2026-08-26T02:15:11.740957Z","2026-05-05T02:43:27.927728Z",[],[]]